32146796
2019
The aim of this study was to make a clinical characterisation of patients with hepatocellular carcinoma and to investigate the expression of a set of molecular markers in patients from the Republic of North Macedonia. We analysed 60 patients for clinicopathologic factors, and we investigated tumour tissue and surrounding liver tissue for immunoexpression of E-cadherin, Î²-catenin, cyclin D1, and p53. Infection with hepatitis virus B and C (p
clinicopathological features; molecular markers; survival; hepatocellular carcinoma.
